PPP1R1B

PPP1R1B Full Name

protein phosphatase 1, regulatory (inhibitor) subunit 1B

PPP1R1B Introduction

PPP1R1B, officially known as Protein Phosphatase 1 Regulatory Inhibitor Subunit 1B, is a member of the dopamine- and cAMP-regulated phosphoprotein (DARPP-32) family. Encoded by the PPP1R1B gene located on human chromosome 17q12, this intracellular protein is predominantly expressed in the brain, particularly within the medium spiny neurons of the striatum. Unlike general phosphatase inhibitors, PPP1R1B possesses a unique structural motif that allows it to function as a bifunctional molecular switch. Its classification as a "inhibitor-1" homolog underscores its evolutionary conserved role in fine-tuning synaptic signaling cascades, positioning it as a critical node connecting neurotransmitter reception to long-term cellular adaptation.The functional activity of PPP1R1B is governed by a classic phosphorylation-dependent mechanism, which converts it from an inert state into a potent inhibitor of protein phosphatase-1 (PP1). Upon phosphorylation at threonine 34 by protein kinase A (PKA), the protein undergoes a conformational change that exposes its PP1-binding motif, allowing it to competitively block the catalytic subunit of PP1. This inhibition is reversible, as dephosphorylation at the same residue by protein phosphatase 2A (PP2A) or calcineurin rapidly restores its basal state. Furthermore, phosphorylation at serine 130 by casein kinase 2 enhances the affinity of the threonine-34 site for PKA, creating a synergistic "priming" effect that amplifies the signal-to-noise ratio of dopaminergic transmission.

Figure 1. Schematic Summary of Ppp1r1b-lncRNA-ChIRP Assay and Bioinformatic Pipeline. (Hwang J H, 2023)

Physiological Roles in Neurotransmission and Plasticity
Within the basal ganglia circuitry, PPP1R1B serves as a master integrator of dopamine and glutamate signals, directly modulating the excitability of striatal output neurons. By inhibiting PP1, the phosphorylated protein disinhibits downstream substrates such as the NMDA receptor and the AMPA receptor trafficking machinery, thereby strengthening corticostriatal synaptic plasticity. This regulatory action underpins two opposing forms of long-term synaptic modification: long-term potentiation (LTP) and long-term depression (LTD), depending on the temporal pattern of dopamine release. Moreover, PPP1R1B plays an essential role in gating the behavioral responses to psychostimulants, motor learning, and habit formation, making it a central determinant of reward-guided behaviors and procedural memory consolidation.

Current Research Frontiers and Therapeutic Potential
Contemporary investigations into PPP1R1B are expanding beyond conventional neurotransmission, exploring its involvement in neuroinflammation, energy metabolism, and epigenetic regulation. Recent proteomic studies have identified novel interacting partners, including histone deacetylases and kinase scaffolds, suggesting that PPP1R1B may influence transcriptional programs via PP1-dependent chromatin remodeling. Pharmacologically, small-molecule modulators that mimic the phosphorylated state of PPP1R1B are being evaluated as cognitive enhancers or as adjunct therapies for levodopa-induced dyskinesia. Furthermore, optogenetic and chemogenetic tools designed to manipulate PPP1R1B activity in specific neuronal subpopulations are providing unprecedented insights into its cell-type-specific functions, promising to unlock new therapeutic strategies for addiction, depression, and other dopamine-related disorders.

Alternate Names for PPP1R1B

PPP1R1B; protein phosphatase 1, regulatory (inhibitor) subunit 1B; DARPP32; DARPP-32; protein phosphatase 1 regulatory subunit 1B; dopamine and cAMP-regulated neuronal phosphoprotein 32;

• 1.Hwang J H, Kang X, Wolf C, et al. Mapping chromatin occupancy of Ppp1r1b-lncRNA genome-wide using chromatin isolation by RNA purification (ChIRP)-seq. Cells, 2023, 12(24): 2805.